Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery

Lignende værker

• Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A
  af: Motwani, Jayashree, et al.
  Udgivet: (2020)
• Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study
  af: Windyga, Jerzy, et al.
  Udgivet: (2020)
• Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis
  af: Yu, Zhenwei, et al.
  Udgivet: (2018)
• Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B
  af: Windyga, Jerzy, et al.
  Udgivet: (2020)
• Combined Antihaemophilic Globulin and Christmas Factor Deficiency in Haemophilia
  af: Verstraete, Marc, et al.
  Udgivet: (1955)